Provided by Tiger Trade Technology Pte. Ltd.

Avalyn Pharma

38.37
+1.243.34%
Post-market: 38.370.00000.00%19:30 EDT
Volume:159.50K
Turnover:6.13M
Market Cap:1.70B
PE:-16.47
High:39.68
Open:37.13
Low:37.06
Close:37.13
52wk High:40.17
52wk Low:24.15
Shares:44.33M
Float Shares:16.67M
Volume Ratio:0.93
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3300
EPS(LYR):-87.7434
ROE:-68.34%
ROA:-41.74%
PB:4.27
PE(LYR):-0.44

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2026

Major Issues Report

Form 8-K - Current report
Aug 11, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 01, 2026

Major Issues Report

Form 8-K - Current report
Jun 17, 2026

Major Issues Report

Form 8-K - Current report
Jun 03, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 03, 2026

Major Issues Report

Form 8-K - Current report
May 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 05, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 01, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 29, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 24, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 08, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933